The primary in vitro antitumor screening of "half-mustard type" phenothiazines.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 9413180)

Published in Anticancer Res on January 20, 1998

Authors

M A Wuonola1, M G Palfreyman, N Motohashi, M Kawase, S Gabay, J Nacsa, J Molnár

Author Affiliations

1: SCRIPTGEN Pharmaceuticals, Inc., Medford, MA 02155, USA.

Articles by these authors

ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol (2002) 4.11

Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci (1998) 2.39

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med (2001) 2.10

Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J Neurosci (1998) 1.99

Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab (1999) 1.87

Kinetic measurements of DNA hybridization on an oligonucleotide-immobilized 27-MHz quartz crystal microbalance. Anal Chem (1998) 1.81

Right-sided partial sternotomy for minimally invasive valve operation: "open door method". Ann Thorac Surg (1998) 1.66

Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res (1999) 1.62

Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J Neurosci (1999) 1.56

Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia. J Neurosci (1999) 1.39

Transfer function analysis of the circulation in patients undergoing sevoflurane anesthesia. Can J Anaesth (1999) 1.39

The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. J Neurosci (2000) 1.34

Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques. J Virol (2001) 1.31

A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J Virol (1994) 1.30

The relationship between GABA concentrations in brain and cerebrospinal fluid. Brain Res (1979) 1.21

Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab (1998) 1.21

Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen. J Immunol (2001) 1.19

The development of a new mouse model of global ischemia: focus on the relationships between ischemia duration, anesthesia, cerebral vasculature, and neuronal injury following global ischemia in mice. Brain Res (1998) 1.19

MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation. Cell Death Differ (2013) 1.14

Simultaneous determination of 3,4-dihydroxyphenylalanine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-methoxyphenylalanine, norepinephrine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5-hydroxyindoleacetic acid in rat cerebrospinal fluid and brain by high-performance liquid chromatography with electrochemical detection. J Neurochem (1982) 1.12

Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome. Rheumatology (Oxford) (2005) 1.11

alpha-difluoromethyl DOPA, a new enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase. J Neurochem (1978) 1.09

Structural variation in the Waxy gene and differentiation in foxtail millet [Setaria italica (L.) P. Beauv.]: implications for multiple origins of the waxy phenotype. Mol Genet Genomics (2002) 1.08

Effects of amino and imino acridines on tumor necrosis factor production by human leukocytes. Anticancer Res (1995) 1.06

Structural characterization of nuclear poly(A)-protein particles in rat liver. Eur J Biochem (1983) 1.04

Cerebrospinal fluid GABA as an index of brain GABA activity. Clin Neuropharmacol (1983) 1.02

The role of 5-HT2A receptors in antipsychotic activity. Life Sci (1995) 1.02

Attempts to detect the presence of teichoic acid in Bacillus anthracis. Acta Microbiol Acad Sci Hung (1971) 1.01

Early decrease of apurinic/apyrimidinic endonuclease expression after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab (1999) 1.01

Circulatory and respiratory responses to capsaicin, 5-hydroxytryptamine and histamine in rats pretreated with capsaicin. Arch Int Pharmacodyn Ther (1967) 1.00

Superoxide-dependent formation of hydroxyl radical catalyzed by transferrin. FEBS Lett (1983) 1.00

Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. Virology (1995) 1.00

Copper-zinc superoxide dismutase prevents the early decrease of apurinic/apyrimidinic endonuclease and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke (1999) 1.00

In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells. In Vivo (2005) 1.00

MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1989) 0.99

Structure and function of a novel coliphage-associated sialidase. FEMS Microbiol Lett (2000) 0.99

Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett Appl Microbiol (2010) 0.99

Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site. Mol Pharmacol (1990) 0.98

Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons. J Pharmacol Exp Ther (1995) 0.97

Some parameters affecting the activity of monoamine oxidase in purified bovine brain mitochondria. J Neurochem (1976) 0.97

Effects of benapyrzine, a new antiparkinson drug, on dopamine uptake into corpus striatum. Eur J Pharmacol (1974) 0.97

Syntheses of 15N-enriched polyamines. Chem Pharm Bull (Tokyo) (1984) 0.97

Antibacterial effect of some phenothiazine compounds and R-factor elimination by chlorpromazine. Acta Microbiol Acad Sci Hung (1976) 0.95

Antitumor potential and possible targets of phenothiazine-related compounds. Curr Drug Targets (2000) 0.95

3,5-diacetyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells. Anticancer Res (2000) 0.94

Constituents of Carpobrotus edulis inhibit P-glycoprotein of MDR1-transfected mouse lymphoma cells. Anticancer Res (2010) 0.94

Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo. Cancer Lett (1999) 0.94

Production of human PTH(1-34) via a recombinant DNA technique. Biochem Biophys Res Commun (1994) 0.92

High-performance liquid chromatographic method for the determination of plasma allantoin. J Chromatogr (1983) 0.91

Three-dimensional dental cast analyzing system using laser scanning. Am J Orthod Dentofacial Orthop (1996) 0.91

Evidence for a spin-aligned neutron-proton paired phase from the level structure of (92)Pd. Nature (2011) 0.90

Effects of mycotoxins on human immune functions in vitro. Toxicol In Vitro (2001) 0.90

Determination of methylglyoxal as 2-methylquinoxaline by high-performance liquid chromatography and its application to biological samples. J Chromatogr (1987) 0.90

The pharmacology of GABA-transaminase inhibitors. Biochem Pharmacol (1981) 0.89

The metabolic conversion of L-glutamate to pyrrolidone carboxylate in rat tissues. Biochem Z (1965) 0.89

Effects of age on levels of cysteine, glutathione and related enzyme activities in livers of mice and rats and an attempt to replenish hepatic glutathione level of mouse with cysteine derivatives. Mech Ageing Dev (1996) 0.89

Inhibition of monoamine synthesis by irreversible blockade of aromatic aminoacid decarboxylase with alpha-monofluoromethyldopa. Life Sci (1979) 0.88

The transcriptional regulator YY1 binds to the 5'-terminal region of B19 parvovirus and regulates P6 promoter activity. J Virol (1994) 0.88

Reversal of multidrug resistance of tumor cells. Anticancer Res (2001) 0.88

Intraoperative TEE during mitral valve repair: does it predict early and late postoperative mitral valve dysfunction? Ann Thorac Surg (1998) 0.88

Changes in regional cerebral blood flow during acute electroconvulsive therapy in patients with depression: positron emission tomographic study. Br J Psychiatry (2007) 0.88

Studies on antituberculotic action of some phenothiazine derivatives in vitro. Zentralbl Bakteriol Orig A (1977) 0.88

Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid. J Cereb Blood Flow Metab (2000) 0.88

Inhibitory effects of hyaluronan on [14C]arachidonic acid release from labeled human synovial fibroblasts. Jpn J Pharmacol (1992) 0.88

Secondary structure of pre-mRNA in nuclear ribonucleoprotein particles. Mol Biol Rep (1975) 0.87

Studies of flavin-adenine dinucleotide-requiring enzymes and phenothiazines. II. Structural requirements for D-amino acid oxidase inhibition. Biochem Pharmacol (1966) 0.87

Effect of capsaicin on the cat's nictitating membrane. Acta Physiol Acad Sci Hung (1966) 0.86

Evidence for an exotic S= -2, Q= -2 baryon resonance in proton-proton collisions at the CERN SPS. Phys Rev Lett (2004) 0.86

Effect of hypotension severity on hippocampal CA1 neurons in a rat global ischemia model. Brain Res (2000) 0.86

Effectiveness of fructose-modified chitosan as a scaffold for hepatocyte attachment. Biol Pharm Bull (1997) 0.86

Methylated cap formation by enzymes bound to nuclear informofer particles. Mol Biol Rep (1978) 0.85

Studies of flavin-adenine dinucleotide-requiring enzymes and phenothiazines. 3. Inhibition kinetics with highly purified D-amino acid oxidase. Biochem Pharmacol (1967) 0.85

A comparison of the effects of reversible and irreversible inhibitors of aromatic L-amino acid decarboxylase on the half-life and other pharmacokinetic parameters of oral L-3,4-dihydroxyphenylalanine. Drug Metab Dispos (1983) 0.84

Attenuation of nitric oxide synthase induction in IRF-1-deficient glial cells. Brain Res (1997) 0.84

In vitro biological activity of prenylflavanones. Anticancer Res (2001) 0.84

Antimicrobial activity of new coumarin derivatives. Arzneimittelforschung (2001) 0.84

Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas using anti-HBxAg monoclonal antibody. Pathol Oncol Res (2001) 0.84

Tremorigenic and convulsant actions of intracerebrally administered vegetative poisons in the mouse. Acta Physiol Acad Sci Hung (1967) 0.84

Interaction between antibiotics and non-conventional antibiotics on bacteria. Int J Antimicrob Agents (2000) 0.84

MDL 72145, an enzyme-activated irreversible inhibitor with selectivity for monoamine oxidase type B. J Neurochem (1984) 0.84

Spinal malignant lymphoma appearing after radiation and chemotherapy of a pineal region tumor. Surg Neurol (1996) 0.84

Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships. J Med Chem (1985) 0.84

Two-dimensional changes in soft tissue profile following surgical mandibular advancement in Japanese retrognathic adults. Int J Adult Orthodon Orthognath Surg (2001) 0.84

Biosynthesis and degradation of methylglyoxal in animals. Prog Clin Biol Res (1989) 0.84

Biological activity of feijoa peel extracts. Anticancer Res (2001) 0.84

Concentrations of D-lactate and its related metabolic intermediates in liver, blood, and muscle of diabetic and starved rats. Res Exp Med (Berl) (1992) 0.84

Stimulation of liver functions in hierarchical co-culture of bone marrow cells and hepatocytes. Cytotechnology (1998) 0.83

[A case of adult hemolytic-uremic syndrome associated with Escherichia coli O157 infections]. Nihon Shokakibyo Gakkai Zasshi (1998) 0.83

Monamine-depleting properties of a new and very potent enzyme-activated irreversible inhibitor of aromatic aminoacid decarboxylase: alpha-monofluoromethyldopa [proceedings]. Br J Pharmacol (1979) 0.83

Inhibition of peripheral sympathetic function by alpha-monofluoromethyldopa, an irreversible inhibitor of aromatic amino acid decarboxylase [proceedings]. Br J Pharmacol (1979) 0.83

Analysis of the stimulatory action of capsaicin on receptors and sensory fibres of the small intestine in the cat. Further contribution to the problem of pain. Acta Physiol Acad Sci Hung (1968) 0.83

Cytotoxicities and anti-herpes simplex virus activities of diterpenes isolated from Euphorbia species. Planta Med (2001) 0.83

Reversal of multidrug resistance by amitriptyline in vitro. Anticancer Res (1996) 0.83

Human parathyroid hormone: efficient synthesis in Escherichia coli using a synthetic gene, purification and characterization. Int J Pept Protein Res (1994) 0.83

NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations. Eur J Pharmacol (1991) 0.83

Studies of monoamine oxidases: properties of the enzyme in bovine and rabbit brain mitochondria. J Neurochem (1974) 0.83

The functional consequences of inhibition of monoamine oxidase type B: comparison of the pharmacological properties of L-deprenyl and MDL 72145. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.83